List of works - Antonio Durando

5-Fluorouracil, epirubicin and cyclophosphamide versus epirubicin and paclitaxel in node-positive early breast cancer: a phase-III randomized GONO-MIG5 trial

scientific article published on 10 December 2015

A phase II study of three-weekly docetaxel and weekly trastuzumab in HER2-overexpressing advanced breast cancer.

scientific article published in January 2004

Androgen receptor expression is a significant prognostic factor in estrogen receptor positive breast cancers

scientific article published on 03 February 2010

Axillary Dissection vs. no Axillary Dissection in Breast Cancer Patients With Positive Sentinel Lymph Node: A Single Institution Experience

scientific article published on 01 November 2019

Capecitabine in combination with docetaxel and epirubicin in patients with previously untreated, advanced breast carcinoma

scientific article published in March 2003

Continuation of trastuzumab beyond disease progression

scientific article published on 01 April 2005

Dose-dense adjuvant chemotherapy in HER2-positive early breast cancer patients before and after the introduction of trastuzumab: Exploratory analysis of the GIM2 trial

scientific article published on 13 November 2019

Dose-dense adjuvant chemotherapy in premenopausal breast cancer patients: A pooled analysis of the MIG1 and GIM2 phase III studies.

scientific article published on 9 December 2016

Fluorouracil and dose-dense chemotherapy in adjuvant treatment of patients with early-stage breast cancer: an open-label, 2 × 2 factorial, randomised phase 3 trial

scientific article published on 2 March 2015

High miR-21 expression in breast cancer associated with poor disease-free survival in early stage disease and high TGF-beta1

scientific article published on 19 October 2008

Metaplastic breast carcinoma: pathology and clinical outcome.

scientific article published in January 2003

Micropapillary ductal carcinoma in situ of the breast: an inter-institutional study

scientific article published on 13 November 2009

Outcome of patients with HER2-positive advanced breast cancer progressing during trastuzumab-based therapy

scientific article published on 01 April 2006

Phase II open-label study of bevacizumab combined with neoadjuvant anthracycline and taxane therapy for locally advanced breast cancer

scientific article published in May 2013

Prognostic significance of changes in CA 15-3 serum levels during chemotherapy in metastatic breast cancer patients

scientific article published on 03 May 2006

Randomised phase 3 open-label trial of first-line treatment with gemcitabine in association with docetaxel or paclitaxel in women with metastatic breast cancer: a comparison of different schedules and treatments.

scientific article

Retrospective evaluation of clinical outcomes in patients with HER2-positive advanced breast cancer progressing on trastuzumab-based therapy in the pre-lapatinib era.